Class II-associated invariant chain peptide as predictive immune marker in minimal residual disease in acute myeloid leukemia

The majority of patients with acute myeloid leukemia (AML) reach complete remission after high-dose chemotherapy. Still, half of these patients experience a relapse due to presence of minimal residual disease (MRD). Here we discuss the poor prognostic role of class II-associated invariant chain pept...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncoimmunology
Main Authors: van Luijn, Marvin M, van den Ancker, Willemijn, van Ham, S Marieke, van de Loosdrecht, Arjan A
Formato: Artigo
Idioma:Inglês
Publicado em: Taylor & Francis 2014
Assuntos:
Author's View
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4353169/
https://ncbi.nlm.nih.gov/pubmed/25964856
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/21624011.2014.941737
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados